Schneeweis Christian, Wirth Matthias, Saur Dieter, Reichert Maximilian, Schneider Günter
a II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München , München , Germany.
b German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) , Heidelberg , Germany.
Small GTPases. 2018 Nov 2;9(6):457-464. doi: 10.1080/21541248.2016.1262935. Epub 2017 Jan 20.
EGFR signaling has a critical role in oncogenic KRAS-driven tumorigenesis of the pancreas, whereas it is dispensable in other organs. The complex signaling network engaged by oncogenic KRAS and its modulation by EGFR signaling, remains incompletely understood. In order to study early signaling events activated by oncogenic KRAS in the pancreas, we recently developed a novel model system based on murine primary pancreatic epithelial cells enabling the time-specific expression of mutant Kras from its endogenous promoter. Here, we discuss our findings of a Kras-induced autocrine EGFR loop, how this loop is integrated by the MYC oncogene, and point to possible translational implications.
表皮生长因子受体(EGFR)信号传导在致癌性KRAS驱动的胰腺肿瘤发生中起关键作用,而在其他器官中则并非必需。致癌性KRAS参与的复杂信号网络及其受EGFR信号传导的调节,目前仍未完全明确。为了研究致癌性KRAS在胰腺中激活的早期信号事件,我们最近基于小鼠原代胰腺上皮细胞开发了一种新型模型系统,能够从其内源启动子实现突变型Kras的时间特异性表达。在此,我们讨论关于Kras诱导的自分泌EGFR环的研究结果,该环如何被MYC癌基因整合,并指出可能的转化意义。